Aratana Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PETX and buy or sell other stocks, ETFs, and their options commission-free!About PETX
Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT.
CEOCraig A. Tooman, MBA
CEOCraig A. Tooman, MBA
Employees—
Employees—
HeadquartersLeawood, Kansas
HeadquartersLeawood, Kansas
Founded2010
Founded2010
Employees—
Employees—
PETX Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.16
52 Week high$7.16
52 Week low$3.30
52 Week low$3.30
Stock Snapshot
Aratana Therapeutics(PETX) trades at $4.92.
On 2026-03-09, Aratana Therapeutics(PETX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0.
Over the past 52 weeks, Aratana Therapeutics(PETX) stock has traded between a high of $7.16 and a low of $3.30.
Over the past 52 weeks, Aratana Therapeutics(PETX) stock has traded between a high of $7.16 and a low of $3.30.